Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
28.19
+1.53 (5.74%)
At close: May 1, 2026, 4:00 PM EDT
27.75
-0.44 (-1.56%)
After-hours: May 1, 2026, 5:06 PM EDT
Forte Biosciences Employees
Forte Biosciences had 19 employees as of December 31, 2025. The number of employees increased by 5 or 35.71% compared to the previous year.
Employees
19
Change
5
Growth
35.71%
Revenue / Employee
n/a
Profits / Employee
-$3,651,316
Market Cap
690.04M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 19 | 5 | 35.71% |
| Sep 30, 2025 | 16 | 5 | 45.45% |
| Jun 30, 2025 | 17 | 6 | 54.55% |
| Mar 31, 2025 | 14 | 3 | 27.27% |
| Dec 31, 2024 | 14 | 5 | 55.56% |
| Sep 30, 2024 | 11 | 2 | 22.22% |
| Jun 30, 2024 | 11 | 4 | 57.14% |
| Mar 31, 2024 | 11 | 4 | 57.14% |
| Dec 31, 2023 | 9 | 3 | 50.00% |
| Sep 30, 2023 | 9 | 3 | 50.00% |
| Jun 30, 2023 | 7 | 1 | 16.67% |
| Mar 31, 2023 | 7 | 2 | 40.00% |
| Dec 31, 2022 | 6 | 1 | 20.00% |
| Sep 30, 2022 | 6 | -4 | -40.00% |
| Jun 30, 2022 | 6 | -4 | -40.00% |
| Mar 31, 2022 | 5 | -4 | -44.44% |
| Dec 31, 2021 | 5 | -4 | -44.44% |
| Jun 30, 2021 | 10 | 5 | 100.00% |
| Mar 31, 2021 | 9 | 8 | 800.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 625 |
| Arvinas | 246 |
| Allogene Therapeutics | 152 |
| Absci | 140 |
| Solid Biosciences | 121 |
| Alpha Tau Medical | 121 |
| Adlai Nortye | 109 |
| BridgeBio Oncology Therapeutics | 92 |
FBRX News
- 24 days ago - Forte Biosciences Announces Pricing of $150 Million Public Offering - Business Wire
- 25 days ago - Forte Biosciences Announces Proposed Public Offering - Business Wire
- 4 weeks ago - Forte Biosciences, Inc. Announces 2025 Results and Provides Update - Business Wire
- 6 weeks ago - Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules - Business Wire
- 2 months ago - Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules - Business Wire
- 2 months ago - Forte Biosciences, Inc. to Present at Upcoming Investor Meetings - Business Wire
- 4 months ago - Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules - Business Wire
- 6 months ago - Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update - Business Wire